Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 35-2027985 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The foundation conducted activities described in code section 170(c)(2)(b) by distributing medicines, prescription drugs, and other pharmaceutical products and medical supplies (pharmaceutical products), donated to it by eli LILLY and company (donor) to the ill, needy, and infants who met the foundation's eligibility requirements (eligible patients). The pharmaceutical products it received from the donor were distributed for charitable purposes and at no charge, for the care of eligible patients. During 2024, the foundation distributed over $4 Billion of products to over 164,000 eligible patients for Diabetes, immune disorders, cancer, women's, men's and children's health, mental health, and pain.
Total Revenue
$4.1B
FY2024
Total Expenses
$4.1B
FY2024
Net Assets
$0
Program Ratio
—
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.